Disorders of Leukocytes

Leukopenia is an abnormally low leukocyte count, while leukocytosis is a very high leukocyte number. Leukopenia results from bone marrow disorders, autoimmune diseases, or infections that impair leukocyte production. Leukocytosis typically occurs as a natural response when the body detects an invading infectious agent and releases more leukocytes into the bloodstream to combat the threat.

Bone marrow disorders like multiple myeloma and aplastic anemia impair the marrow's ability to produce adequate leukocytes. These conditions directly damage bone marrow tissue, reducing leukocyte production. Additionally, autoimmune diseases like lupus and viral infections such as HIV can trigger the immune system to attack cells involved in leukocyte production, further contributing to leukopenia.

Leukemia is indicated by an extremely high leukocyte count exceeding 100,000 cells per microliter. These blood cancers are categorized by progression speed and affected cell lineage. Acute myeloid leukemia aggressively spreads through the myeloid lineage, while chronic lymphocytic leukemia progresses slowly and affects lymphoid cells.

When the body detects an invading infectious agent, it increases the release of leukocytes into the bloodstream to combat the threat. This natural response mobilizes immune cells to fight the infection. However, extremely elevated counts above 100,000 cells per microliter may indicate leukemia rather than a normal infection response.

Infectious mononucleosis, often caused by the Epstein-Barr virus, increases atypical lymphocytes in the bloodstream. These abnormal lymphocytes may be mistaken for monocytes during blood analysis. The presence of atypical lymphocytes is a characteristic finding in mononucleosis and helps distinguish it from other leukocyte disorders.

Autoimmune diseases like lupus trigger the immune system to attack cells involved in leukocyte production within the bone marrow. This self-directed immune attack reduces the body's ability to generate new leukocytes, resulting in abnormally low leukocyte counts. The destruction of leukocyte-producing cells leads to persistent leukopenia.

Acute myeloid leukemia is an aggressively spreading cancer affecting the myeloid cell lineage with rapid progression. Chronic lymphocytic leukemia progresses slowly and affects lymphoid cells. Both are categorized as leukemias when leukocyte counts exceed 100,000 cells per microliter, but their progression rates and affected cell types differ significantly.